KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Shares Issued (2016 - 2025)

Medpace Holdings' Shares Issued history spans 11 years, with the latest figure at $22.7 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 1706.76% year-over-year to $22.7 million; the TTM value through Dec 2025 reached $57.0 million, up 259.45%, while the annual FY2025 figure was $57.0 million, 259.45% up from the prior year.
  • Shares Issued reached $22.7 million in Q4 2025 per MEDP's latest filing, up from $8.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $25.9 million in Q1 2025 to a low of $351000.0 in Q2 2025.
  • Average Shares Issued over 5 years is $6.2 million, with a median of $3.8 million recorded in 2021.
  • Peak YoY movement for Shares Issued: plummeted 85.07% in 2021, then soared 1706.76% in 2025.
  • A 5-year view of Shares Issued shows it stood at $2.4 million in 2021, then soared by 136.98% to $5.8 million in 2022, then crashed by 73.56% to $1.5 million in 2023, then dropped by 17.4% to $1.3 million in 2024, then skyrocketed by 1706.76% to $22.7 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Shares Issued are $22.7 million (Q4 2025), $8.0 million (Q3 2025), and $351000.0 (Q2 2025).